Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Grace Liao

Optometrist Glendale, AZ Doctor of Optometry

NPI 1699127225 CMS profile 2684804

5865 W Utopia Rd, Glendale, AZ 85308

Open in the dashboard

General payments

$6,972

74 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Grace Liao of Glendale, AZ is reported in the CMS Open Payments database as having received $6,972 across 74 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,087 12
2024 General $1,141 13
2023 General $1,156 13
2022 General $1,076 12
2019 General $2,511 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Grace Liao
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Grace Liao were reported at $1,087. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Grace Liao Optometrist median Middle half National median
2019 $2,511 $159 $67–$371 $163
2020 $0 $72 $29–$165 $114
2021 $0 $125 $46–$292 $132
2022 $1,076 $162 $66–$374 $149
2023 $1,156 $177 $72–$406 $160
2024 $1,141 $188 $77–$427 $164
2025 $1,087 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Johnson & Johnson Vision Care, Inc. $3,144 27 payments
  2. CooperVision Inc. $1,899 23 payments
  3. Alcon Vision LLC $1,805 22 payments
  4. Glaukos Corporation $124 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $3,500 24 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,750 12 payments
  3. Travel and Lodging $1,181 1 payment
  4. Food and Beverage $541 37 payments
Products named General payments · program years 2019–2025
  1. Acuvue $3,144 27 payments
  2. AIR OPTIX $1,805 22 payments
  3. Clariti Contact Lens $1,719 20 payments
  4. Biofinity Contact Lens $180 3 payments
  5. KXL system (not refurbished) $75 1 payment
  6. CE-marked KXLA system $49 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 17 billing codes

Paid by Medicare

$2,878

Medicare's payments for the services billed

Medicare patients

46

Average age 73

Services billed

69

31 women, 15 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 54%
Ischemic heart disease 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

74 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record